science top stories popular news  

Daily non-political popular news in brief.

Potato wart eyed as risk to potato production

06-18-2007 · EurekAlert!

While many may be familiar with potato late blight, the plant disease responsible for widespread potato shortages, the lesser known potato wart has the potential to be as devastating to economies that depend on potato production, say plant pathologists with The American Phytopathological Society (APS).

Read more »

Keywords: potato, wart, eyed, risk, production

« Previous | Next »

Similar news on "Potato wart eyed as risk to potato production":

  1. Advance in understanding of blood pressure gene could lead to new treatments
    02-04-2007 · EurekAlert!
    Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
    Similar news · Read more »
  2. Molecule discovered to be key to pain sensitivity
    10-22-2006 · EurekAlert!
    Sensitivity to pain and the risk of developing chronic pain appear to be influenced by a molecule known to be required for the production of major neurotransmitters. In the November issue of Nature Medicine, an international research team describes this unexpected role for the molecule called BH4 and their findings that a particular set of variations in a human gene involved in synthesizing the molecule, appears to reduce pain sensitivity.
    Similar news · Read more »
  3. Testosterone turns male juncos into blustery hunks -- and bad dads
    10-15-2007 · EurekAlert!
    The ability to ramp up testosterone production appears to drive male dark-eyed juncos to find and win mates, but it comes with an evolutionary cost. Big fluctuations in testosterone may also cause males to lose interest in parenting their own young, scientists have learned.
    Similar news · Read more »
  4. Growth factors given with chemotherapy associated with increased risk of blood diseases
    02-06-2007 · EurekAlert!
    Women with breast cancer who receive compounds that stimulate white blood cell production to help their bodies better tolerate chemotherapy are at an increased risk of developing a type of leukemia or a condition called myelodysplastic syndrome, according to a new study in the February 7, Journal of the National Cancer Institute. The authors note that the absolute risk of the conditions is very small, but that risk should still be taken into consideration when making treatment decisions.
    Similar news · Read more »
  5. No evidence that widely prescribed statins protect against prostate cancer
    08-09-2007 · EurekAlert!
    A large community-based study refutes previous findings that statins -- a top-selling drug class, worldwide -- might cut one's risk of developing prostate cancer by reducing production of the male hormones that fuel cancer growth.
    Similar news · Read more »
  6. Climate change threatens wild relatives of key crops
    05-21-2007 · EurekAlert!
    Wild relatives of plants such as the potato and the peanut are at risk of extinction, threatening a valuable source of genes that are necessary to boost the ability of cultivated crops to resist pests and tolerate drought, according to a new study released today by scientists of the Consultative Group on International Agricultural Research (CGIAR). The culprit is climate change, the researchers said.
    Similar news · Read more »
  7. Xylitol reduces risk of cavities
    02-15-2007 · EurekAlert!
    The sugar substitute xylitol affects the bacterial composition of the oral cavity even in low doses. On the other hand, a relatively high intake is needed to counteract the production of acid between the teeth, according to Pernilla Lif Holgerson in the dissertation she will defend at Umeå University in Sweden on February 23.
    Similar news · Read more »
  8. Malaria and Epstein-Barr virus linked to pediatric cancer in Africa
    06-07-2007 · EurekAlert!
    Arnaud Chene and colleagues have identified CIDRla as the first microbial protein able to spur a latently EBV-infected cell into active production. Their results suggest that P. falciparum-derived proteins can lead to a direct reactivation of EBV during acute malaria infection, increasing the risk of Burkitt lymphoma development for children living in malaria-endemic areas.
    Similar news · Read more »
  9. New Joslin research identifies sirtuin protein instrumental in fat production and metabolism
    08-15-2007 · EurekAlert!
    A new Joslin Diabetes Center-led study has identified a protein found in fat cells that may play a major role in how fat is produced and stored, offering a new target for treatments to prevent obesity and reduce the risk for type 2 diabetes. This latest research appears in the August 2007 issue of Cell Metabolism.
    Similar news · Read more »
  10. Blue eyes -- A clue to paternity
    10-23-2006 · EurekAlert!
    Before you request a paternity test, spend a few minutes looking at your child's eye color. According to studies, published this week in Behavioral Ecology and Sociobiology, the human eye color reflects a simple, predictable and reliable genetic pattern of inheritance. The researchers show that blue-eyed men find blue-eyed women most attractive. According to the researchers, it is because there could be an unconscious male adaptation for the detection of paternity, based on eye color.
    Similar news · Read more »